merz gmbh & co. kgaa

What merz gmbh & co. kgaa does

Merz GmbH & Co. KGaA is a German family-owned diversified healthcare company founded in 1918 by pharmacist and chemist Friedrich Merz in Frankfurt am Main. The company operates through three specialized business divisions: Merz Aesthetics, which provides minimally invasive aesthetic treatments including injectable fillers, botulinum neurotoxin, and non-invasive microfocused ultrasound therapy for skin rejuvenation; Merz Therapeutics, which markets botulinum neurotoxin-based treatments for neurological movement disorders such as dystonia and spasticity, including a proprietary formulation free of complex proteins; and Merz Lifecare, which sells consumer health and personal care products under brands including tetesept, SOS, Zirkulin, Merz Spezial, and Brooklyn Soap Company.

Merz's commercial model is segmented by buyer type. Aesthetics and Therapeutics generate revenue through direct enterprise sales engagement with specialist healthcare professionals (dermatologists, plastic surgeons, neurologists, and movement disorder specialists), while Lifecare reaches end consumers through retail and pharmacy distribution channels. Marketing is executed across multiple channels including corporate websites, LinkedIn, Facebook, Instagram, and YouTube. The company maintains its century-long family ownership following a generational transition completed in January 2025 and expanded its executive leadership with the appointment of Dr. Almuth Steinkühler as CFO in October 2025. In July 2026, the Merz Group placed its debut Schuldschein (promissory note) for €450 million, three times the original target, indicating strong financial capacity and investor confidence.

Name

merz gmbh & co. kgaa

Legal name

Merz Pharma GmbH

Website

https://merz.de

Company type

Private

Founded year

1918

Operating status

Operating

Short description

Merz GmbH & Co. KGaA is a German family-owned healthcare company founded in 1918, operating three divisions: Merz Aesthetics (fillers, botulinum neurotoxin, ultrasound therapy), Merz Therapeutics (neurological botulinum toxin treatments), and Merz Lifecare (consumer brands tetesept, SOS, Zirkulin, Merz Spezial, Brooklyn Soap Company).

Ownership category

akta.pro rank

Product category

Aesthetic Medicine & Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Aesthetic medicine products
• Botulinum neurotoxin therapy
• Dermal filler treatments
• Neurological movement disorder treatment
• Consumer health brands

Headquarters

HQ city

Frankfurt am Main

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Merz Aesthetics: Revenue from aesthetic medicine products including fillers, botulinum neurotoxin, and ultrasound therapy devices for dermatologists and aesthetic physicians
2. Merz Therapeutics: Revenue from pharmaceutical products treating neurological movement disorders using botulinum neurotoxin therapies
3. Merz Lifecare: Revenue from consumer health products including tetesept, SOS, Zirkulin, Merz Spezial, and Brooklyn Soap Company brands for health, wellness, body care and natural beauty

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Merz GmbH & Co. KGaA develops, manufactures, and markets pharmaceutical and consumer health products across three divisions: Merz Aesthetics (dermal fillers, botulinum neurotoxin type A, and microfocused ultrasound therapy devices for skin rejuvenation), Merz Therapeutics (botulinum neurotoxin therapies for neurological movement disorders), and Merz Lifecare (consumer health and personal care brands including tetesept, SOS, Zirkulin, Merz Spezial, and Brooklyn Soap Company).

Product overview

Merz GmbH & Co. KGaA is a diversified healthcare company organized into three main business divisions: Merz Aesthetics (aesthetic medicine with fillers, botulinum neurotoxin, and ultrasound therapy), Merz Therapeutics (neurological treatments with botulinum neurotoxin for movement disorders), and Merz Lifecare (consumer health brands including tetesept, SOS, Zirkulin, Merz Spezial, and Brooklyn Soap Company for health, wellness, and beauty products). The company was founded in 1918 and remains family-owned.

Differentiator

Problem solved

Functional benefit

Brands

• Merz Aesthetics: Aesthetic medicine division offering minimally invasive treatments with fillers and botulinum neurotoxin, non-invasive microfocused ultrasound therapy for skin rejuvenation
• Merz Therapeutics
• Merz Lifecare
• tetesept
• SOS
• Zirkulin
• Brooklyn Soap Company

Products and services

• Merz Aesthetics product portfolio Aesthetic medicine product portfolio for specialist dermatologists, plastic surgeons, and aesthetic physicians offering minimally invasive treatments with dermal fillers and botulinum neurotoxin, plus non-invasive microfocused ultrasound therapy to restore skin firmness, lost volume, and individual wrinkles.
• Merz Therapeutics product portfolio Botulinum neurotoxin therapies for patients with neurologically caused movement disorders (such as dystonia and spasticity), offering flexible and individually adapted therapy solutions for neurologists and movement disorder specialists.
• tetesept brand products Health and wellness consumer brand sold through pharmacy and retail, offering products supporting consumer self-care and well-being.
• SOS brand products Consumer health brand under Merz Lifecare offering health and wellness products for everyday self-care, sold through pharmacy and retail.
• Zirkulin brand products Consumer health brand under Merz Lifecare offering health and wellness products for everyday self-care, sold through pharmacy and retail.
• Merz Spezial brand products Consumer brand under Merz Lifecare offering health and personal care products sold through pharmacy and retail.
• Brooklyn Soap Company brand products Natural beauty and body care brand under Merz Lifecare offering products for body care and natural beauty, sold through retail and pharmacy channels.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Revance Therapeutics: Aesthetic and therapeutic company with the differentiated Daxxify neurotoxin and the RHA line of dermal fillers, competing head-to-head with Merz Aesthetics across injectables and skin rejuvenation.
• Hugel: South Korean specialty company with broad botulinum toxin (Letybo, Botulax) and dermal filler portfolios, competing globally with Merz Aesthetics and increasingly expanding into therapeutic neurotoxin indications.
• Evolus: US aesthetic medicine company commercializing Jeuveau (prabotulinumtoxinA), a competing neurotoxin in the aesthetic space, directly challenging Merz Aesthetics in dermatology and plastic surgery channels.
• Hologic (Cynosure): Through its Cynosure division, Hologic markets energy-based aesthetic devices (including skin-tightening platforms) overlapping with Merz Aesthetics' microfocused ultrasound offering in non-invasive rejuvenation.

Direct peers

• Galderma: Pure-play dermatology and aesthetics pharmaceutical company offering injectables, skincare, and therapeutic dermatology products—directly competing with Merz Aesthetics in fillers and skin rejuvenation while sharing a focus on specialty physician channels.
• Ipsen: French specialty pharma company that markets Dysport (botulinum toxin) for both therapeutic and aesthetic uses, sharing Merz's dual aesthetic/therapeutic neurotoxin positioning and competing with Merz Therapeutics in movement-disorder indications.
• Sinclair Pharma: Aesthetic medicine-focused specialty company with a portfolio of fillers, threads, and bio-stimulators, sharing Merz Aesthetics' focus on physician-administered minimally invasive rejuvenation treatments.
• Beiersdorf: German personal-care company behind Eucerin, Nivea, and La Prairie, competing most directly with Merz Lifecare's consumer health, body-care, and natural-beauty brands in pharmacy and retail channels.

Broad incumbents

• AbbVie (Allergan Aesthetics): Global pharmaceutical leader whose Allergan Aesthetics division fields Botox—the dominant neurotoxin franchise across both aesthetic and therapeutic indications—making AbbVie the principal large-scale competitor to Merz's combined aesthetics/therapeutics neurotoxin platform.
• Bayer: Diversified German pharma and consumer-health major with consumer-care, OTC, and prescription businesses that overlap with Merz Lifecare (consumer health), Merz Therapeutics (pharma), and Merz Aesthetics' German-European footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@merzaestheticsglobal
• Facebookfacebook.com/aesthetics.merz
• LinkedInlinkedin.com/company/merz-pharma-group
• Instagraminstagram.com/merzaesthetics

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about merz gmbh & co. kgaa